Skip to main content
Erschienen in: BMC Geriatrics 1/2018

Open Access 01.12.2018 | Research article

Validation of an automatically generated screening score for frailty: the care assessment need (CAN) score

verfasst von: Jorge G. Ruiz, Shivani Priyadarshni, Zubair Rahaman, Kimberly Cabrera, Stuti Dang, Willy M. Valencia, Michael J. Mintzer

Erschienen in: BMC Geriatrics | Ausgabe 1/2018

Abstract

Background

Frailty is a state of vulnerability to stressors that is prevalent in older adults and is associated with higher morbidity, mortality and healthcare utilization. Multiple instruments are used to measure frailty; most are time-consuming. The Care Assessment Need (CAN) score is automatically generated from electronic health record data using a statistical model. The methodology for calculation of the CAN score is consistent with the deficit accumulation model of frailty. At a 95 percentile, the CAN score is a predictor of hospitalization and mortality in Veteran populations. The purpose of this study was to validate the CAN score as a screening tool for frailty in primary care.

Methods

This is a cross-sectional, validation study compared the CAN score with a 40-item Frailty Index reference standard based on a comprehensive geriatric assessment. We included community-dwelling male patients over age 65 from an outpatient geriatric medicine clinic. We calculated the sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of the CAN score.

Results

184 patients over age 65 were included in the study: 97.3% male, 64.2% White, 80.9% non-Hispanic. The CGA-based Frailty Index defined 14.1% as robust, 53.3% as prefrail and 32.6% as frail. For the frail, statistical analysis demonstrated that a CAN score of 55 provides sensitivity, specificity, PPV and NPV of 91.67, 40.32, 42.64 and 90.91% respectively whereas at a score of 95 the sensitivity, specificity, PPV and NPV were 43.33, 88.81, 63.41, 77.78% respectively. Area under the receiver operating characteristics curve was 0.736 (95% CI = .661–.811).

Conclusion

CAN score is a potential screening tool for frailty among older adults; it is generated automatically and provides acceptable diagnostic accuracy. Hence, the CAN score may be a useful tool to primary care providers for detection of frailty in their patient panels.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s12877-018-0802-7) contains supplementary material, which is available to authorized users.
Abkürzungen
ADLS
Activities of daily living
ANOVA
Analysis of Variance
AUC
Area under the curve.
CAN
Care Assessment Need
CGA
Comprehensive Geriatric Assessment
EHR
Electronic health record
IADLS
Instrumental Activities of daily living
NPV
Negative predictive value
PPV
Positive predictive value
ROC
Receiver Operator Characteristics
VA
Veterans Affairs
VSAFE
Veterans’ Successful Aging for Frail Elders

Background

Frailty is a state of vulnerability to stressors which may result in higher morbidity, mortality and healthcare utilization in older adults. There are currently two major conceptualization of frailty: the frailty phenotype, which requires the presence of three or more of five components: weight loss, exhaustion, weakness, slowness, and low physical activity [1]; and the deficit accumulation model, which combines symptoms, diseases, conditions and disability into a score called the frailty index (FI) [2]. Such screening can lead to the identification of frail patients in need of diagnostic and management strategies to improve outcomes.
Screening for frailty traditionally involves questionnaires or scales administered in healthcare settings. Several reliable and valid self-report questionnaires have been effectively employed in these settings. They vary by the number of items included, whether administered face-to-face, or self-completed during a clinical encounter or delivered by mail [3, 4]. Health care providers, however, may not have the time to administer these instruments to older individuals; patients may not be willing or able to answer these questions. Clinicians would benefit from an automated tool that assists them in identifying older persons with frailty.
In comparison to the administration of time consuming questionnaires which are subject to interrater variability, automated screenings can have a significant impact on early detection and subsequent evidence-based interventions for frailty in primary care settings. In the US, the Veterans Health Administration has developed and implemented the care assessments needs (CAN) score as a predictive analytic tool that reflects the likelihood of hospitalization or death in an individual patient compared with other patients. The CAN score has been designed to assist primary care providers in patient management and care coordination. The CAN score is generated from VA electronic health record data that includes information on medical conditions, number of diagnoses, vital signs, medications, laboratory tests, use of care coordination resources and overall VA healthcare utilization [5, 6]. The CAN is an objective, efficient, cost-effective and automatically generated score that is ideal as a screening modality. A study of over four million VA patients receiving primary care showed that a CAN score of 95 or higher was a good predictor of hospitalization and death at 90 days and one year with good areas under the receiver operating characteristic (ROC) curve [5, 6]. The methodology for calculation of the CAN score is consistent with the deficit accumulation model of frailty [2] thereby providing a conceptual framework for its use as a valid tool in frailty screening. Using the deficit accumulation model as the conceptual framework, Clegg et al. created an electronic frailty index (eFI) from existing electronic health record data. Similar to the CAN score the eFI showed predictive validity for outcomes of mortality, hospitalization and care home admission. [7]. Currently, the CAN score is available to all VA primary care physicians; the eFI has not been routinely implemented as a tool in clinical practice.
Leveraging the capabilities of electronic health record (EHR) as a data repository for frailty screening may lead to earlier recognition of frail older patients and potentially improve healthcare outcomes for this population. The management of populations of older patients with higher prevalence of frailty substantiates the use of the EHR to identify patients at risk. Automated screening has the potential to bring many more individuals with frailty to the attention of their primary care providers. The purpose of this study is to validate the CAN score as an automated screening tool for frailty in older Veterans.

Methods

This is a cross-sectional study of community-dwelling Veterans 65 years and older coming to geriatric clinics at a VA Medical Center in the Southeast. Our geriatric clinic is a primary care clinic for adults 65-years and older. The clinic follows the Patient-Centered Medical Home (PCMH) care delivery model whereby patient treatment is coordinated through primary care geriatric medicine physicians including attending physicians and fellows (trainees who have completed internal medicine or family medicine residency training). In the VA Healthcare System, this model is referred to as Patient Aligned Care Teams (PACTs). Study patients included 184 of 371 patients enrolled in the Veterans’ Successful Aging for Frail Elders (VSAFE) clinical demonstration project. Study patients met the following criteria: a CGA and a CAN score were available within a 7-day interval, spoke English, and were seen between July 8, 2016 and June 16, 2017. The CGA served as the reference standard [810] and included physical, psychological, functional and social evaluations and when applicable, diagnostic tests. The patients were stratified as robust (FI is ≤0.10), prefrail (FI between 0.10 and 0.20) or frail (FI is ≥0.20) as recommended by Song et al. [11] based on a 40-item frailty index (see Additional file 1) generated from the CGA following the deficit accumulation approach to measuring frailty [12]. Nine geriatric medicine fellows supervised by geriatric medicine staff physicians performed the CGAs during scheduled outpatient clinic appointments. For each patient, we matched the date of the CGA-based frailty index to the CAN-generated admission and death risk at 1 year score generated within a 7-day period. Geriatric medicine fellows and geriatric staff physicians were not aware of the CAN scores on that week. The study was approved by the Miami VA Healthcare System Institutional Review Board as a quality improvement project. Patients were not reimbursed for participation.
Statistical analysis of the data was performed using the SPSS for Apple Macintosh 24 software package (IBM SPSS, Inc., Chicago, IL, USA). Differences among groups on demographic variables, and CAN scores were analyzed by the Levene’s test for homogeneity of variance (p = 0.05) and differences between the robust, prefrail and frail groups were analyzed by one-way ANOVA or Welch ANOVA followed by either Tukey’s or the Games-Howell post hoc test when Levene’s values were greater than 0.05 or below 0.05, respectively. Data is presented as mean ± standard deviation. Comparisons of proportions were carried out using the Pearson chi-square test of homogeneity. A Pearson correlation was run to assess the relationship between the CAN score, frailty index, Charlson Comorbidity Index (CCI) and total activities of daily living (ADLs) and instrumental activities of daily living (IADLs) scores (sum of the individual values). Associations were considered significant if P < 0.05. Contingency table analysis was utilized to calculate the sensitivity, specificity, positive and negative predictive values (PPV and NPV) at two percentile scores: the values of 95 [5, 6] and 55 - a score that provided a sensitivity over 90% to identify frailty. A desirable screening test would be one that is both highly sensitive and highly specific and, for clinical purposes, displays a high PPV. [13] Receiver Operator Characteristics (ROC) analysis was utilized to assess the CAN score ability to differentiate: robust, prefrail and frail individuals. These analyses were also used to identify the optimal balance between sensitivity and specificity. Area under the curve (AUC) was used to examine improved diagnostic performance. Sample size calculations using an alpha level of 0.05, beta level of 0.10 (90% power), for a minimum expected AUC of 0.70 (moderately accurate test: ≥ 0.7, ≤ 0.9), ratio of frail to non-frail subjects of 3 and null hypothesis value of 0.5 required at least 96 subjects for the present study (MedCalc Statistical Software version 17.9.7, MedCalc Software bvba, Ostend, Belgium; https://​www.​medcalc.​org; 2017).

Results

The demographic and frailty-related characteristics of the 184 participants were different across the frailty index defined robust, pre-frail and frail groups (Table 1). The frailty index showed that 32.6% of the subjects (n = 60) were frail. Compared with robust and prefrail individuals, those with frailty were more likely to be older, have more dependence on ADLS and IADLS, and have higher frailty indexes, and CCI scores. As is common in VA studies, our cohort included few (n = 5) women; all scored as frail. There were no differences discovered among Caucasian participants or among non-Hispanics participants.
Table 1
Participant characteristics stratified by Frailty status
 
Total
(n = 184, 100%)
Robust
(n = 26, 14.1%)
Prefrail
(n = 98, 53.3%)
Frail
(n = 60, 32.6%)
p
Age, mean (SD)
77.34 (8.32)
73.58a (5.78)
77.26b (8.02)
79.10b (9.25)
0.004
Males, n (%)
179 (97.3%)
26a (100%)
98a (100%)
55b (91.7%)
0.005
Caucasian, n (%)
113 (64.2%)
19 (79.2%)
61 (65.5%)
33 (55.9%)
0.394
Not Hispanic, n (%)
148 (80.9%)
23 (88.5%)
77 (79.4%)
48 (80.0%)
0.566
At least 1 ADL dependency, n (%)
44 (23.9%)
0a (0.0%)
11b (11.2%)
33c (55.0%)
< 0.0005
At least 1 IADL dependency, n (%)*
71 (100%)
3a (12.0%)
19b (19.8%)
49c (81.7%)
< 0.0005
Frailty Index, mean (SD)
0.21 (0.13)
0.06a (0.03)
0.16b (0.04)
0.37c (0.09)
< 0.0005
Charlson Comorbidity Index, mean (SD)
6.16 (2.37)
4.2a (1.65)
5.97b (2.23)
7.33c (2.23)
< 0.0005
CAN Score, mean (SD)
67.92 (27.13)
44.04a (28.18)
65.55b (26.1)
82.15c (18.98)
< 0.0005
*Data missing on 3 patients. SD = standard deviation; n = number of participants. Data with different superscript letters are significantly different p < 0.05, according to the post hoc ANOVA statistical analysis for continuous variables and chi square for categorical variables. The column means test table assigns a superscript letter (a, b or c) to the robust, prefrail and frail groups. If a pair of values is significantly different, the values have different subscript letters assigned to them. If a pair of values are not significantly different, the values will have the same superscript letters assigned to them. Data without superscripts is not significantly different between robust, prefrail and frail groups
The CAN score was statistically significantly different between robust, prefrail and frail groups [Welch’s F(2, 65.526) = 24.089, p <  0.0005]. The mean CAN score increased from the robust (44.04, SD = 28.179, 95% CI [32.66–55.42]), to the prefrail (65.55, SD = 26.1, 95% CI [60.32–70.78]) and frail (82.15, SD = 18.983, 95% CI [77.25–87.05]) groups. The box plot shows that the CAN score increases from the robust to the prefrail and the frail groups (Fig. 1). Post hoc analysis revealed the increase from robust to prefrail (21.51, 95% CI [6.57–36.46]) was statistically significant (p = 0.003), as well as the increase from prefrail to frail (16.599, 95%CI [8.08–25.12], p < 0.0005. ROC curves were for the frail versus the combined robust and prefrail groups showed an area under the curve (AUC) of 0.736 (95% CI = .661–.811).
Table 2 shows the variations in specificity and sensitivity by 95th and 55th percentiles for patients with frailty. At the 95th percentile, specificity is higher than sensitivity; PPV and NPV are both high. At the 55th percentile, sensitivity is higher than specificity; NPV is dramatically higher than PPV. In clinical medicine, the PPV, a percentage based on the fraction: true positives / (true positives + false positives), may be most helpful. At the 95th percentile, approximately 2 of 3 patients would be frail; at the 55th percentile, approximately 2 of 5 older patients would be frail. We found moderate positive correlations between the CAN score and both the frailty index (r = .454, p = 0.01) and the CCI (r = .335, p <  0.0005). The correlations with the total ADLS score (r = .184, p = 0.05) and IADLS total score (r = .287, p = 0.01) were positive but small.
Table 2
Sensitivity, specificity, PPV and NPV of the CAN score for Frailty screening
CAN Score cut-off
Sensitivity (95% CI)
Specificity (95% CI)
PPV (95% CI)
NPV (95% CI)
≥ 55th percentile
91.67%
(81.61–97.24)
40.42%
(31.6–49.51)
42.64%
(38.69–46.68)
90.91%
(80.79–95.56)
≥ 95th percentile
43.33%
(30.59–56.76)
88.81%
(82.21–93.60)
63.41%
(49.81–75.17)
77.78%
(73.56–81.49)
CI Confident Intervals, PPV Positive predictive value, NPV Negative predictive value

Discussion

Two existing automated tools, the CAN score and the eFI are good predictors of health care utilization and mortality [5, 14]. However, of the two, only the eFI has been validated as a frailty diagnostic tool [14]. The fact that the CAN score is currently implemented in the largest integrated healthcare system in the US represents an excellent opportunity to test its ability to screen for frailty in a population of older adults. The use of the CAN score as a system-wide automated screening program to identify frailty in older adults will allow physicians to direct evidence-based interventions to improve clinical outcomes to those most in need. Compared to a CGA-based frailty index used as the reference standard for diagnosing frailty, this study provides validation that the automated CAN score can differentiate frail and non-frail patients. This automated approach can serve as an initial frailty assessment for screening patient panels in primary care settings.
Individuals with higher CAN scores were more likely to be frail than those with lower scores. Concurrent validity is evident by the significant positive correlations obtained between the two CAN scores used in this study and the CGA-based frailty index scores. ROC analysis demonstrated that the AUC was fair and able to provide frailty cut-off scores with high sensitivity and NPV at a 55th percentile and high specificity and PPV at a 95th percentile. To our knowledge, this is the first time that the CAN score has been validated for frailty screening.
Obstacles to early detection of frailty are multiple, including a lack of familiarity with the condition, unrecognized symptoms and signs, denial or lack of awareness of the condition, interpretation of symptoms as part of the normal aging process by patients, family members and primary care clinicians, and time constraints to conduct appropriate evaluations in busy primary care practices. Furthermore, screening for frailty should be an easy, quick, and low-cost process able to detect most patients with the condition.
Currently in primary care settings, a frailty screening test with high sensitivity (over 90%) may be more desirable than high specificity, as it would minimize the risk of missing a patient with frailty - a serious medical condition for which an intervention is available. It is, however, important to realize that CGA-based frailty index, used to confirm the results of frailty screening, is time consuming and often the expertise to administer CGA-based frailty index is unavailable. A high specificity would be desirable to minimize the number of false positives which can burden already strained geriatric services. In this study, the CAN score at a 95th percentile demonstrated a low sensitivity but a high specificity for identifying frailty. Healthcare organizations with limited access to geriatric expertise and resources may decide that a high specificity CAN score of 95 will ensure the cost-effectiveness of the frailty screening program. Under this screening strategy, most individuals without frailty will not be unnecessarily referred for CGA. Conversely, organizations with available geriatric services may prefer a CAN score of 55 corresponding to a higher sensitivity but a lower specificity for the identification of frailty. The CAN score sensitivity at 55 is superior to most frailty questionnaires and scales [1517] and comparable to other performance based measures (e.g., gait speed, short physical performance battery) [3]; however, the AUC and specificity are lower than most instruments [3, 15, 17]. The PPV of 42.6% (57.4% false positives) will result in a number of patients being referred for a CGA-based frailty index who will not test positive for frailty. This high false positive rate is comparable with widely used screening tests such as the prostate specific antigen (PSA) for prostate cancer of around 30% [1820], a condition with similar prevalence to that of frailty in the older population, and superior to the under 20% PPV of low dose CT for lung cancer [21, 22], a condition with a lower prevalence. Importantly, unlike those tests, the CAN score does not result in the need for invasive testing. The CGA-based frailty index requires only an office visit and may have the additional benefit of uncovering other unrecognized geriatric syndromes or conditions.
Clearly, there are resource implications depending on the cut-off score used.
At the 95th percentile most would be frail; however, the absolute numbers would likely be less than using a 55th percentile. Furthermore, it is very likely that many in the 95th percentile, even those not formally diagnosed with frailty, would already be receiving comprehensive care for complex illness in other clinical programs. If resources are limited, targeting patients in the 95th percentile who are not already receiving specialized care is a reasonable alternative to initiate a frailty screening program. If resources are available to perform a CGA-based frailty assessment on all individuals with a CAN of 55, a frailty assessment program, that also excludes those receiving specialized care, could be initiated. Identifying 4 of 10 patients with true frailty is patient-centered, quality of life focused, and will also include the reward of additional organizational cost reductions. Another strategy to address the high false positive rates may be repeat testing over time [23]. Contrasting with the difficulties of administering questionnaires or conducting performance-based tests, repeated testing with the CAN score becomes a feasible and more cost-effective approach. As frailty may be a reversible [24, 25], having several data points at which the CAN score is generated over time would improve the accuracy of screening. This approach will require further study.
A major strength of this work is the widespread use of the validated CGA as a clinical tool based on millions of patient visits. Another strength of our study is the relatively large sample size and the completeness of our data. Although initially not considered in the design and development of this study, the CAN score fits within the deficit accumulation paradigm of frailty which supports construct validity between the tools. Limitations of our study was the inclusion of mostly male patients enrolled in a geriatric medicine clinic. Older patients in other primary care clinics with a larger number of older women may be different from this sample. Although the number of participants appears low, the sample exceeds the calculated minimum number of participants needed.

Conclusions

The CAN score has validity as a screening tool for detection of frailty and warrants further investigation regarding its applicability in primary care settings. The CAN score may help clinicians recognize frailty sooner and implement strategies for improving patient outcomes in older patients with frailty. Further studies are needed to help identify and refine new data or measurements that will improve the screening accuracy of clinical tools to find older adults with frailty.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
The Miami VA Healthcare System Institutional Review Board (IRB) has deemed the study as exempt from IRB approval. Written informed consent was waived by the IRB because the study was conducted as a review of an existing quality improvement database.
Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.CrossRefPubMed Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.CrossRefPubMed
2.
Zurück zum Zitat Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722–7.CrossRefPubMed Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722–7.CrossRefPubMed
3.
Zurück zum Zitat Clegg A, Rogers L, Young J. Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age Ageing. 2015;44(1):148–52.CrossRefPubMed Clegg A, Rogers L, Young J. Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age Ageing. 2015;44(1):148–52.CrossRefPubMed
4.
Zurück zum Zitat Buta BJ, Walston JD, Godino JG, Park M, Kalyani RR, Xue QL, Bandeen-Roche K, Varadhan R. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53–61.CrossRefPubMed Buta BJ, Walston JD, Godino JG, Park M, Kalyani RR, Xue QL, Bandeen-Roche K, Varadhan R. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53–61.CrossRefPubMed
5.
Zurück zum Zitat Wang L, Porter B, Maynard C, Evans G, Bryson C, Sun H, Gupta I, Lowy E, McDonell M, Frisbee K, et al. Predicting risk of hospitalization or death among patients receiving primary care in the veterans health administration. Med Care. 2013;51(4):368–73.CrossRefPubMed Wang L, Porter B, Maynard C, Evans G, Bryson C, Sun H, Gupta I, Lowy E, McDonell M, Frisbee K, et al. Predicting risk of hospitalization or death among patients receiving primary care in the veterans health administration. Med Care. 2013;51(4):368–73.CrossRefPubMed
6.
Zurück zum Zitat Fihn SD, Francis J, Clancy C, Nielson C, Nelson K, Rumsfeld J, Cullen T, Bates J, Graham GL. Insights from advanced analytics at the veterans health administration. Health Aff (Millwood). 2014;33(7):1203–11.CrossRef Fihn SD, Francis J, Clancy C, Nielson C, Nelson K, Rumsfeld J, Cullen T, Bates J, Graham GL. Insights from advanced analytics at the veterans health administration. Health Aff (Millwood). 2014;33(7):1203–11.CrossRef
7.
Zurück zum Zitat Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, Mohammed MA, Parry J, Marshall T. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353–60.CrossRefPubMedPubMedCentral Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, Mohammed MA, Parry J, Marshall T. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353–60.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Abellan van Kan G, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B. The assessment of frailty in older adults. Clin Geriatr Med. 2010;26(2):275–86.CrossRefPubMed Abellan van Kan G, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B. The assessment of frailty in older adults. Clin Geriatr Med. 2010;26(2):275–86.CrossRefPubMed
9.
Zurück zum Zitat Maly RC, Hirsch SH, Reuben DB. The performance of simple instruments in detecting geriatric conditions and selecting community-dwelling older people for geriatric assessment. Age Ageing. 1997;26(3):223–31.CrossRefPubMed Maly RC, Hirsch SH, Reuben DB. The performance of simple instruments in detecting geriatric conditions and selecting community-dwelling older people for geriatric assessment. Age Ageing. 1997;26(3):223–31.CrossRefPubMed
10.
Zurück zum Zitat Pialoux T, Goyard J, Lesourd B. Screening tools for frailty in primary health care: a systematic review. Geriatr Gerontol Int. 2012;12(2):189–97.CrossRefPubMed Pialoux T, Goyard J, Lesourd B. Screening tools for frailty in primary health care: a systematic review. Geriatr Gerontol Int. 2012;12(2):189–97.CrossRefPubMed
11.
Zurück zum Zitat Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58(4):681–7.CrossRefPubMed Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58(4):681–7.CrossRefPubMed
14.
Zurück zum Zitat Clegg A, Bates C, Young J, Ryan R, Nichols L, Teale EA, Mohammed MA, Parry J, Marshall T: Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing 2017. Clegg A, Bates C, Young J, Ryan R, Nichols L, Teale EA, Mohammed MA, Parry J, Marshall T: Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing 2017.
15.
Zurück zum Zitat Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc. 2012;60(8):1478–86.CrossRefPubMed Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc. 2012;60(8):1478–86.CrossRefPubMed
16.
Zurück zum Zitat Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012;13(10):e437–44.CrossRefPubMed Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012;13(10):e437–44.CrossRefPubMed
17.
Zurück zum Zitat Hoogendijk EO, van der Horst HE, Deeg DJ, Frijters DH, Prins BA, Jansen AP, Nijpels G, van Hout HP. The identification of frail older adults in primary care: comparing the accuracy of five simple instruments. Age Ageing. 2013;42(2):262–5.CrossRefPubMed Hoogendijk EO, van der Horst HE, Deeg DJ, Frijters DH, Prins BA, Jansen AP, Nijpels G, van Hout HP. The identification of frail older adults in primary care: comparing the accuracy of five simple instruments. Age Ageing. 2013;42(2):262–5.CrossRefPubMed
18.
Zurück zum Zitat Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J Urol. 1992;147(3 Pt 2):841–5.CrossRefPubMed Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J Urol. 1992;147(3 Pt 2):841–5.CrossRefPubMed
19.
Zurück zum Zitat Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, de Kernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151(5):1283–90.CrossRefPubMed Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, de Kernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151(5):1283–90.CrossRefPubMed
20.
Zurück zum Zitat Schroder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Prostate cancer detection at low prostate specific antigen. J Urol. 2000;163(3):806–12.CrossRefPubMed Schroder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Prostate cancer detection at low prostate specific antigen. J Urol. 2000;163(3):806–12.CrossRefPubMed
21.
Zurück zum Zitat Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013;369(10):920–31.CrossRefPubMedPubMedCentral Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013;369(10):920–31.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2015;12(3):273–6.CrossRefPubMed McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2015;12(3):273–6.CrossRefPubMed
23.
Zurück zum Zitat Pijpers E, Ferreira I, Stehouwer CD, Nieuwenhuijzen Kruseman AC. The frailty dilemma. Review of the predictive accuracy of major frailty scores. Eur J Intern Med. 2012;23(2):118–23.CrossRefPubMed Pijpers E, Ferreira I, Stehouwer CD, Nieuwenhuijzen Kruseman AC. The frailty dilemma. Review of the predictive accuracy of major frailty scores. Eur J Intern Med. 2012;23(2):118–23.CrossRefPubMed
24.
Zurück zum Zitat Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med. 2006;166(4):418–23.CrossRefPubMed Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med. 2006;166(4):418–23.CrossRefPubMed
25.
Zurück zum Zitat Borsch-Supan A, Brandt M, Hunkler C, Kneip T, Korbmacher J, Malter F, Schaan B, Stuck S, Zuber S, Team SCC. Data resource profile: the survey of health, ageing and retirement in Europe (SHARE). Int J Epidemiol. 2013;42(4):992–1001.CrossRefPubMedPubMedCentral Borsch-Supan A, Brandt M, Hunkler C, Kneip T, Korbmacher J, Malter F, Schaan B, Stuck S, Zuber S, Team SCC. Data resource profile: the survey of health, ageing and retirement in Europe (SHARE). Int J Epidemiol. 2013;42(4):992–1001.CrossRefPubMedPubMedCentral
Metadaten
Titel
Validation of an automatically generated screening score for frailty: the care assessment need (CAN) score
verfasst von
Jorge G. Ruiz
Shivani Priyadarshni
Zubair Rahaman
Kimberly Cabrera
Stuti Dang
Willy M. Valencia
Michael J. Mintzer
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
BMC Geriatrics / Ausgabe 1/2018
Elektronische ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-018-0802-7

Weitere Artikel der Ausgabe 1/2018

BMC Geriatrics 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.